Green Approaches in Medicinal Chemistry for Sustainable Drug Design: Methods

— —

Bimal Krishna Banik (Vice President of Research and Education Development, Community Health Systems of South Texas, USA)

Green Approaches in Medicinal Chemistry for Sustainable Drug Design

Methods

Bimal Krishna Banik (Vice President of Research and Education Development, Community Health Systems of South Texas, USA)

$405.95

Paperback

Forthcoming
Pre-Order now

QTY:

English

Elsevier - Health Sciences Division
07 June 2024

Pharmacology; Organic chemistry

Series: Advances in Green and Sustainable Chemistry

Green Approaches in Medicinal Chemistry for Sustainable Drug Design: Methods, Second Edition reveals how medicinal chemistry can play a direct role in addressing this issue. After providing essential context on the growth of green chemistry in relation to drug discovery, the book identifies a range of practical techniques and useful insights, revealing how medicinal chemistry techniques can be used to improve efficiency, mitigate failure, and increase the environmental benignity of the entire drug discovery process. Drawing on the knowledge of a global experts, the book encourages the growth of green medicinal chemistry, and supports medicinal chemists, drug discovery researchers, pharmacologists, and more.

This volume covers synthesis methods following green chemistry principles, contributing to sustainability by saving energy, using lesser toxic reagents/solvents/catalysts and environmentally benign sources, including plants and agricultural materials.

Edited by: Bimal Krishna Banik (Vice President of Research and Education Development Community Health Systems of South Texas USA)
Imprint: Elsevier - Health Sciences Division
Country of Publication: United States
Edition: 2nd edition
Dimensions: Height: 229mm, Width: 152mm,
Weight: 450g
ISBN: 9780443161643
ISBN 10: 044316164X
Series: Advances in Green and Sustainable Chemistry
Pages: 600
Publication Date: 07 June 2024
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Forthcoming

Since being awarded his PhD by the Indian Association for the Cultivation of Science, Calcutta, Professor Banik has held positions as a Postdoctoral Fellow at Case Western Reserve University and Stevens Institute of Technology; Tenured Full Professor in Chemistry and First President’s Endowed Professor in Science & Engineering at the University of Texas-Pan American, Edinburg; an Assistant Professor in Molecular Pathology at the University of Texas M. D. Anderson Cancer Center, Houston; and a Research Assistant Professor in Chemistry & Chemical Biology at Stevens Institute of Technology, New Jersey. Since 2014, he has been the Vice President of Research & Education Development of Community Health Systems of South Texas. Professor Banik has designed, synthesized, and identified novel beta lactams derived from polyaromatic compounds as anticancer agents. He is involved in the asymmetric synthesis, biological evaluation, delivery of compounds to increase the effectiveness and mechanism of actions studies of beta lactams and polyaromatic compounds as anticancer agents. As the Principal Investigator, Professor Banik has been awarded $7.25 million in grants from the US National Institutes of Health, US National Cancer Institute, and Kleberg Foundation. He has also has more than 315 publications to his name (including peer-reviewed papers and patents, book chapters, books, perspectives, commentaries and reviews) along with approximately 460 presentation abstracts with 6000 citations. He is a reviewer of 93, editorial board member of 28, editor-in-chief of 9, founder of 4, associate editor of 4 and guest editor of 6 research journals. Furthermore, Professor Banik has presided over numerous research sessions at top conferences in the field, including one at the Nobel Prize celebration in Germany.